WallStSmart
APTO

Aptose Biosciences Inc

NASDAQ: APTO · HEALTHCARE · BIOTECHNOLOGY

$1.71
+0.00% today

Updated 2026-10-30

Market cap
$4.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-36.38
Dividend yield
—
52W range
$0 – $0
Volume
—

Aptose Biosciences Inc (APTO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Operating cash flow$-14.92M$-11.87M$-5.88M$-10.25M$-6.62M$-3.53M$-6.03M$-3.21M$-4.94M$-9.94M$-9.89M$-12.17M$-10.22M$-23.21M$-21.56M$-33.89M$-43.30M$-32.32M$-44.59M$-35.98M
Capital expenditures$477614.00$68001.00$19004.00$58332.00$161467.00$1895.00$8257.00$0.00$20275.00$301980.00$258000.00$3728.00$13000.00$329000.00$102000.00$79000.00$212000.00$24000.00$29000.00$5000.00
Depreciation————————————————————
Stock-based comp———$409174.00$409174.00$166805.00$494446.00$492003.00$498699.00$2.41M$2.50M$1.71M$817000.00$4.28M$2.30M$21.44M$12.95M$5.21M$3.65M$1.06M
Free cash flow$-15.40M$-11.93M$-5.90M$-10.31M$-6.78M$-3.53M$-6.04M$-3.21M$-4.96M$-10.25M$-10.15M$-12.18M$-10.24M$-23.54M$-21.66M$-33.97M$-43.52M$-32.35M$-44.62M$-35.98M
Investing cash flow————————————————————
Financing cash flow————————————————————
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00———————
Share repurchases————————————————————
Debt repayment————————————————————
Net change in cash—————————————$4.67M$64.54M$37.55M$-78.28M$-2.14M——

Frequently asked questions

How much free cash flow does APTO generate?

APTO produced $-35.98M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.